Broadfin Capital as of March 31, 2019
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 41 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iovance Biotherapeutics (IOVA) | 8.5 | $41M | 4.3M | 9.51 | |
| Nevro (NVRO) | 8.0 | $39M | 623k | 62.51 | |
| Catalyst Pharmaceutical Partners (CPRX) | 6.2 | $30M | 5.9M | 5.10 | |
| Aratana Therapeutics | 5.4 | $26M | 7.3M | 3.60 | |
| Myriad Genetics (MYGN) | 5.1 | $25M | 740k | 33.20 | |
| BioDelivery Sciences International | 4.8 | $23M | 4.4M | 5.30 | |
| Retrophin | 4.8 | $23M | 1.0M | 22.63 | |
| Global Blood Therapeutics In | 4.3 | $21M | 395k | 52.93 | |
| Zogenix | 4.2 | $20M | 372k | 55.01 | |
| Adamas Pharmaceuticals | 3.6 | $18M | 2.5M | 7.11 | |
| Heron Therapeutics (HRTX) | 3.1 | $15M | 608k | 24.44 | |
| Strongbridge Bioph shs usd | 2.9 | $14M | 2.8M | 4.98 | |
| La Jolla Pharmaceuticl Com Par | 2.6 | $13M | 2.0M | 6.43 | |
| Biohaven Pharmaceutical Holding | 2.6 | $13M | 247k | 51.47 | |
| Aclaris Therapeutics (ACRS) | 2.5 | $12M | 2.0M | 5.99 | |
| Recro Pharma | 2.3 | $11M | 1.9M | 5.86 | |
| Mirati Therapeutics | 2.2 | $11M | 148k | 73.30 | |
| Quotient | 2.0 | $9.9M | 1.1M | 9.01 | |
| Incyte Corporation (INCY) | 1.8 | $8.6M | 100k | 86.01 | |
| Nanostring Technologies (NSTGQ) | 1.8 | $8.5M | 356k | 23.93 | |
| Intersect Ent | 1.8 | $8.5M | 264k | 32.15 | |
| Sierra Oncology | 1.7 | $8.3M | 4.8M | 1.71 | |
| Strata Skin Sciences | 1.7 | $8.2M | 2.9M | 2.85 | |
| Dex (DXCM) | 1.7 | $8.0M | 68k | 119.10 | |
| Antares Pharma | 1.6 | $8.0M | 2.6M | 3.03 | |
| Integra LifeSciences Holdings (IART) | 1.6 | $7.9M | 142k | 55.72 | |
| Viewray (VRAYQ) | 1.3 | $6.4M | 867k | 7.39 | |
| Optinose | 1.2 | $6.0M | 586k | 10.30 | |
| Sol Gel Technologies | 1.2 | $5.7M | 848k | 6.77 | |
| Adma Biologics (ADMA) | 1.2 | $5.6M | 1.5M | 3.79 | |
| Vericel (VCEL) | 1.0 | $4.8M | 273k | 17.51 | |
| Livanova Plc Ord (LIVN) | 1.0 | $4.7M | 48k | 97.25 | |
| Flamel Technologies Sa | 0.9 | $4.5M | 3.1M | 1.44 | |
| Neos Therapeutics | 0.9 | $4.2M | 1.6M | 2.61 | |
| Matinas Biopharma Holdings, In | 0.6 | $3.0M | 2.7M | 1.09 | |
| Eiger Biopharmaceuticals | 0.6 | $2.7M | 193k | 13.98 | |
| Teligent | 0.5 | $2.3M | 2.0M | 1.16 | |
| Alphatec Holdings (ATEC) | 0.2 | $1.2M | 443k | 2.65 | |
| Opiant Pharmaceuticals | 0.2 | $1.1M | 86k | 13.13 | |
| Osmotica Pharmaceuticals (RVLPQ) | 0.2 | $1.1M | 308k | 3.60 | |
| Noveliontherapeuti.. | 0.2 | $897k | 729k | 1.23 |
